Literature DB >> 23563267

Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX.

Myunggon Ko1, Jungeun An, Hozefa S Bandukwala, Lukas Chavez, Tarmo Aijö, William A Pastor, Matthew F Segal, Huiming Li, Kian Peng Koh, Harri Lähdesmäki, Patrick G Hogan, L Aravind, Anjana Rao.   

Abstract

TET (ten-eleven-translocation) proteins are Fe(ii)- and α-ketoglutarate-dependent dioxygenases that modify the methylation status of DNA by successively oxidizing 5-methylcytosine to 5-hydroxymethylcytosine, 5-formylcytosine and 5-carboxycytosine, potential intermediates in the active erasure of DNA-methylation marks. Here we show that IDAX (also known as CXXC4), a reported inhibitor of Wnt signalling that has been implicated in malignant renal cell carcinoma and colonic villous adenoma, regulates TET2 protein expression. IDAX was originally encoded within an ancestral TET2 gene that underwent a chromosomal gene inversion during evolution, thus separating the TET2 CXXC domain from the catalytic domain. The IDAX CXXC domain binds DNA sequences containing unmethylated CpG dinucleotides, localizes to promoters and CpG islands in genomic DNA and interacts directly with the catalytic domain of TET2. Unexpectedly, IDAX expression results in caspase activation and TET2 protein downregulation, in a manner that depends on DNA binding through the IDAX CXXC domain, suggesting that IDAX recruits TET2 to DNA before degradation. IDAX depletion prevents TET2 downregulation in differentiating mouse embryonic stem cells, and short hairpin RNA against IDAX increases TET2 protein expression in the human monocytic cell line U937. Notably, we find that the expression and activity of TET3 is also regulated through its CXXC domain. Taken together, these results establish the separate and linked CXXC domains of TET2 and TET3, respectively, as previously unknown regulators of caspase activation and TET enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23563267      PMCID: PMC3643997          DOI: 10.1038/nature12052

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  39 in total

1.  Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation.

Authors:  Jikui Song; Olga Rechkoblit; Timothy H Bestor; Dinshaw J Patel
Journal:  Science       Date:  2010-12-16       Impact factor: 47.728

2.  Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells.

Authors:  Kian Peng Koh; Akiko Yabuuchi; Sridhar Rao; Yun Huang; Kerrianne Cunniff; Julie Nardone; Asta Laiho; Mamta Tahiliani; Cesar A Sommer; Gustavo Mostoslavsky; Riitta Lahesmaa; Stuart H Orkin; Scott J Rodig; George Q Daley; Anjana Rao
Journal:  Cell Stem Cell       Date:  2011-02-04       Impact factor: 24.633

3.  Natural history of eukaryotic DNA methylation systems.

Authors:  Lakshminarayan M Iyer; Saraswathi Abhiman; L Aravind
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

4.  Differentiation of tubular and villous adenomas based on Wnt pathway-related gene expression profiles.

Authors:  Anthony V Nguyen; C Gregory Albers; Randall F Holcombe
Journal:  Int J Mol Med       Date:  2010-07       Impact factor: 4.101

5.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities.

Authors:  Sven Heinz; Christopher Benner; Nathanael Spann; Eric Bertolino; Yin C Lin; Peter Laslo; Jason X Cheng; Cornelis Murre; Harinder Singh; Christopher K Glass
Journal:  Mol Cell       Date:  2010-05-28       Impact factor: 17.970

6.  Structure of the MLL CXXC domain-DNA complex and its functional role in MLL-AF9 leukemia.

Authors:  Tomasz Cierpicki; Laurie E Risner; Jolanta Grembecka; Stephen M Lukasik; Relja Popovic; Monika Omonkowska; David D Shultis; Nancy J Zeleznik-Le; John H Bushweller
Journal:  Nat Struct Mol Biol       Date:  2009-12-13       Impact factor: 15.369

7.  Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.

Authors:  Myunggon Ko; Yun Huang; Anna M Jankowska; Utz J Pape; Mamta Tahiliani; Hozefa S Bandukwala; Jungeun An; Edward D Lamperti; Kian Peng Koh; Rebecca Ganetzky; X Shirley Liu; L Aravind; Suneet Agarwal; Jaroslaw P Maciejewski; Anjana Rao
Journal:  Nature       Date:  2010-12-09       Impact factor: 49.962

8.  CpG islands recruit a histone H3 lysine 36 demethylase.

Authors:  Neil P Blackledge; Jin C Zhou; Michael Y Tolstorukov; Anca M Farcas; Peter J Park; Robert J Klose
Journal:  Mol Cell       Date:  2010-04-23       Impact factor: 17.970

9.  The structural basis for selective binding of non-methylated CpG islands by the CFP1 CXXC domain.

Authors:  Chao Xu; Chuanbing Bian; Robert Lam; Aiping Dong; Jinrong Min
Journal:  Nat Commun       Date:  2011       Impact factor: 14.919

10.  Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates.

Authors:  Daniel Globisch; Martin Münzel; Markus Müller; Stylianos Michalakis; Mirko Wagner; Susanne Koch; Tobias Brückl; Martin Biel; Thomas Carell
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

View more
  172 in total

1.  TET-catalyzed oxidation of intragenic 5-methylcytosine regulates CTCF-dependent alternative splicing.

Authors:  Ryan J Marina; David Sturgill; Marc A Bailly; Morgan Thenoz; Garima Varma; Maria F Prigge; Kyster K Nanan; Sanjeev Shukla; Nazmul Haque; Shalini Oberdoerffer
Journal:  EMBO J       Date:  2015-12-28       Impact factor: 11.598

2.  Pyrene-based quantitative detection of the 5-formylcytosine loci symmetry in the CpG duplex content during TET-dependent demethylation.

Authors:  Liang Xu; Ying-Chu Chen; Jenny Chong; Andrea Fin; Lisa S McCoy; Jun Xu; Chao Zhang; Dong Wang
Journal:  Angew Chem Int Ed Engl       Date:  2014-08-27       Impact factor: 15.336

Review 3.  Advances in the profiling of DNA modifications: cytosine methylation and beyond.

Authors:  Nongluk Plongthongkum; Dinh H Diep; Kun Zhang
Journal:  Nat Rev Genet       Date:  2014-08-27       Impact factor: 53.242

Review 4.  A double take on bivalent promoters.

Authors:  Philipp Voigt; Wee-Wei Tee; Danny Reinberg
Journal:  Genes Dev       Date:  2013-06-15       Impact factor: 11.361

5.  The mysterious presence of a 5-methylcytosine oxidase in the Drosophila genome: possible explanations.

Authors:  Thomas L Dunwell; Liam J McGuffin; Jim M Dunwell; Gerd P Pfeifer
Journal:  Cell Cycle       Date:  2013-09-19       Impact factor: 4.534

6.  Vpr Targets TET2 for Degradation by CRL4VprBP E3 Ligase to Sustain IL-6 Expression and Enhance HIV-1 Replication.

Authors:  Lei Lv; Qi Wang; Yanping Xu; Li-Chung Tsao; Tadashi Nakagawa; Haitao Guo; Lishan Su; Yue Xiong
Journal:  Mol Cell       Date:  2018-06-07       Impact factor: 17.970

Review 7.  TET2: A Novel Epigenetic Regulator and Potential Intervention Target for Atherosclerosis.

Authors:  Yami Liu; Wen Peng; Kai Qu; Xiaolong Lin; Zhaolin Zeng; Jiaojiao Chen; Dangheng Wei; Zuo Wang
Journal:  DNA Cell Biol       Date:  2018-04-13       Impact factor: 3.311

Review 8.  The TET enzymes.

Authors:  Peppi Koivunen; Tuomas Laukka
Journal:  Cell Mol Life Sci       Date:  2017-11-28       Impact factor: 9.261

Review 9.  Protein Interactions at Oxidized 5-Methylcytosine Bases.

Authors:  Gerd P Pfeifer; Piroska E Szabó; Jikui Song
Journal:  J Mol Biol       Date:  2019-08-08       Impact factor: 5.469

10.  SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function.

Authors:  Jie Sun; Xin He; Yinghui Zhu; Zonghui Ding; Haojie Dong; Yimei Feng; Juan Du; Hanying Wang; Xiwei Wu; Lei Zhang; Xiaochun Yu; Allen Lin; Tinisha McDonald; Dandan Zhao; Herman Wu; Wei-Kai Hua; Bin Zhang; Lifeng Feng; Kaoru Tohyama; Ravi Bhatia; Philipp Oberdoerffer; Yang Jo Chung; Peter D Aplan; Jacqueline Boultwood; Andrea Pellagatti; Samer Khaled; Marcin Kortylewski; Flavia Pichiorri; Ya-Huei Kuo; Nadia Carlesso; Guido Marcucci; Hongchuan Jin; Ling Li
Journal:  Cell Stem Cell       Date:  2018-08-23       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.